SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Icahn School of Medicine at Mount Sinai at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Icahn School of Medicine at Mount Sinai brings 7 presentations to SITC 2026 in Phoenix. Its program centres on what makes some tumors hot, or open to immune attack, and others cold, along with AI tools for designing immunotherapy proteins. One concrete item reports interim trial results for blocking IL-1-driven inflammation to stop lung precancers from progressing.

OrganizationSITC 2026 Attendance
Universities & research institutes
Medical school of the Mount Sinai Health System in New York City.
Session
Fri Nov 6
11:45am–12:15pm
Clinical Oral Abstract Session
Clinical
  1. 11:45am–12:00pmVGX-3100 DNA immunotherapy for HPV-16/18–associated cervical high-grade squamous intraepithelial lesions: a phase III randomized trialInovio
  2. 12:00pm–12:15pmIDP-023 allogeneic g-NK cells combined with isatuximab in relapse/refractory multiple myeloma: complete safety, efficacy, and tumor microenvironment remodeling from a Phase 1/2 First-in-Human studyIndapta Therapeutics
Session
Sat Nov 7
5:20pm–6:40pm
AI-driven Protein Design to Enhance Cancer Immunotherapy
AI & data · New agents
  1. 5:26pm–5:44pmProtein Design to Improve Cell TherapiesTechnical University of Denmark
  2. 5:44pm–6:02pmDesigning protein-based hardwares for human immune systemRagon Institute of Mass General, MIT and Harvard
  3. 6:02pm–6:20pmT cell phenotype and protein structure-informed discovery of TCRs for cell therapyNational Cancer Institute
  4. 6:20pm–6:30pmDe novo designed cytokines expand immune signaling to explore and prime novel therapeutic T cell states
  5. 6:30pm–6:40pmTransHAP: a large language model-based framework for antigen predictionMayo Clinic
Talk
Sat Nov 7
6:20pm–6:40pm
Session
Sat Nov 7
5:20pm–6:40pm
Hot and Cold Tumors
Tumor biology
  1. 5:20pm–5:40pmWhat Is Meant By Hot And Cold Tumors?UCLA
  2. 5:40pm–6:00pmIdentifying Determinants of Hot and Cold Tumors by AI-Assisted Perturb-MapIcahn School of Medicine at Mount Sinai
  3. 6:00pm–6:10pmModulation of IDO and PD-L1 expressing immune populations in the melanoma microenvironment with IO102-IO103 and nivolumab-relatlimabMemorial Sloan Kettering Cancer Center
  4. 6:10pm–6:20pmA Molecularly Defined Polymeric Platform for Environmentally Responsive Activation of STING to Enhance Cancer ImmunotherapyVanderbilt University
  5. 6:20pm–6:40pmHot and Cold Tumor DebateUCLA, Icahn School of Medicine at Mount Sinai, Brigham and Women's Hospital
Talk
Sat Nov 7
5:40pm–6:00pm
Session
Sat Nov 7
5:20pm–6:40pm
Oral Abstract Session 4
  1. 5:23pm–5:38pmStromal-directed synthetic CAR T circuits effectively treat solid tumors and protect against on-target off-tumor toxicityUCSF
  2. 5:38pm–5:53pmClassical secretion of IL-18 is associated with improved functionality in armored anti-mKRAS TCR-T cellsHospital of the University of Pennsylvania
  3. 5:53pm–6:08pmCD28 GLYCO-EDITING AUGMENTS CD8 T CELL:TUMOR CELL INTERACTION AND KILLINGNetherlands Cancer Institute
  4. 6:08pm–6:23pmCRISPR Screen Identifies SLC7A5 as a Therapeutic Target to Enhance NK-Mediated Cytotoxicity
  5. 6:23pm–6:38pmProgrammable tumor-colonizing bacteria function as locally retained immune cell engagers for solid tumorsDana-Farber Cancer Institute

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Icahn School of Medicine at Mount Sinai

Tell us what you sell and we’ll find the people at Icahn School of Medicine at Mount Sinai most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction